BioGend Therapeutics Co., Ltd. (TPEX:6733)
26.30
-2.60 (-9.00%)
Jul 30, 2026, 12:45 PM CST
-9.31% (1Y)
| Market Cap | 3.59B -1.3% |
| Revenue (ttm) | 229.81M +28.0% |
| Net Income | -67.11M |
| EPS | -0.55 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 119,000 |
| Open | 29.40 |
| Previous Close | 28.90 |
| Day's Range | 26.15 - 29.80 |
| 52-Week Range | 23.45 - 49.15 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |